49401-088 : Benlysta 200 mg/ml Subcutaneous Solution
NDC: | 49401-088 |
Labeler: | Human Genome Sciences, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Benlysta |
Dosage Form: | Subcutaneous Solution |
Application #: | BLA761043 |
Rev. Date: |
NDC Package Codes:
- 49401-088-02: 1 SYRINGE IN 1 CARTON (49401‑088‑02) > 1 ML IN 1 SYRINGE (49401‑088‑01)
- 49401-088-35: 4 SYRINGE IN 1 CARTON (49401‑088‑35) > 1 ML IN 1 SYRINGE (49401‑088‑01)
- 49401-088-47: 4 SYRINGE IN 1 CARTON (49401‑088‑47) > 1 ML IN 1 SYRINGE (49401‑088‑42)
- 49401-088-50: 1 SYRINGE IN 1 CARTON (49401‑088‑50) > 1 ML IN 1 SYRINGE (49401‑088‑42)
- 49401-088-61: 1 SYRINGE IN 1 CARTON (49401‑088‑61) > 1 ML IN 1 SYRINGE
Active Ingredients:
- Belimumab
Dosage Strength:
- 200 mg/mL
Pharmaceutical Classes:
- B Lymphocyte Stimulator-directed Antibody Interactions [MoA]
- B Lymphocyte Stimulator-specific Inhibitor [EPC]
- Decreased B Lymphocyte Activation [PE]
Related Products:
Based on records with the same trade name.- 49401-101 Benlysta 120 mg/1.5ml Intravenous Injection, Powder, Lyophilized, for Solution by Human Genome Sciences, Inc.
- 49401-102 Benlysta 400 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Human Genome Sciences, Inc.
- 12064-009 Benlysta 120 mg/1.5ml Intravenous Injection, Powder, Lyophilized, for Solution by Glaxosmithkline Manufacturing Spa
- 12064-010 Benlysta 400 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Glaxosmithkline Manufacturing Spa
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 49396-6601Next: 49401-101 >
Related Discussions:
Migraines associated to Benlysta use?
I am going for my fourth Benlysta treatment tomorrow and although I've noticed huge differences in my mobility and j... 10 replies
I am going for my fourth Benlysta treatment tomorrow and although I've noticed huge differences in my mobility and j... 10 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.